DK1296715T3 - Multivalent vaccinesammensætning - Google Patents

Multivalent vaccinesammensætning

Info

Publication number: DK1296715T3
Authority: DK; Denmark
Prior art keywords: vaccine composition; multivalent vaccine; multivalent; composition; vaccine
Prior art date: 2000-06-29

Application number

DK01960390.1T

Other languages

English (en)

Other versions

DK1296715T4 (da

Inventor

Dominique Boutriau

Carine Capiau

Pierre Michel Desmons

Dominique Lemoine

Jan Poolman

Original Assignee

Smithkline Beecham Biolog

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-29

Filing date

2001-06-27

Publication date

2012-02-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27255788&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1296715(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-06-29 Priority claimed from GBGB0015999.6A external-priority patent/GB0015999D0/en

2001-04-03 Priority claimed from GB0108363A external-priority patent/GB0108363D0/en

2001-04-03 Priority claimed from GBGB0108364.1A external-priority patent/GB0108364D0/en

2001-06-27 Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog

2012-02-13 Application granted granted Critical

2012-02-13 Publication of DK1296715T3 publication Critical patent/DK1296715T3/da

2016-03-07 Publication of DK1296715T4 publication Critical patent/DK1296715T4/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
- A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Biotechnology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

DK01960390.1T 2000-06-29 2001-06-27 Multivalent vaccinesammensætning. DK1296715T4 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GBGB0015999.6A GB0015999D0 (en)	2000-06-29	2000-06-29	Novel compounds
GB0108363A GB0108363D0 (en)	2001-04-03	2001-04-03	Vaccine composition
GBGB0108364.1A GB0108364D0 (en)	2001-04-03	2001-04-03	Vaccine composition
PCT/EP2001/007288 WO2002000249A2 (en)	2000-06-29	2001-06-27	Multivalent vaccine composition

Publications (2)

Publication Number	Publication Date
DK1296715T3 true DK1296715T3 (da)	2012-02-13
DK1296715T4 DK1296715T4 (da)	2016-03-07

Family

ID=27255788

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK07116669.8T DK1946769T3 (da)	2000-06-29	2001-06-27	Multivalent vaccinesammensætning med nedsat dosis af Haemophilus influenzae type B
DK01960390.1T DK1296715T4 (da)	2000-06-29	2001-06-27	Multivalent vaccinesammensætning.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK07116669.8T DK1946769T3 (da)	2000-06-29	2001-06-27	Multivalent vaccinesammensætning med nedsat dosis af Haemophilus influenzae type B

Country Status (35)

Country	Link
US (2)	US20030180316A1 (da)
EP (4)	EP2277541A1 (da)
JP (2)	JP4870895B2 (da)
KR (3)	KR100898845B1 (da)
CN (2)	CN1449293B (da)
AP (1)	AP1695A (da)
AT (1)	ATE534402T1 (da)
AU (2)	AU2001281895C1 (da)
BG (2)	BG66238B1 (da)
BR (2)	BR122012003821B8 (da)
CA (2)	CA2783274C (da)
CY (2)	CY1112280T1 (da)
CZ (1)	CZ20024224A3 (da)
DK (2)	DK1946769T3 (da)
DZ (1)	DZ3399A1 (da)
EA (2)	EA011480B1 (da)
EG (1)	EG24742A (da)
ES (2)	ES2385100T3 (da)
HK (1)	HK1055244A1 (da)
HU (3)	HU227893B1 (da)
IL (2)	IL153506A0 (da)
MA (1)	MA25824A1 (da)
MX (1)	MXPA03000198A (da)
MY (1)	MY133981A (da)
NO (1)	NO332495B1 (da)
NZ (1)	NZ523319A (da)
OA (1)	OA12302A (da)
PE (1)	PE20020126A1 (da)
PL (2)	PL393584A1 (da)
PT (2)	PT1946769E (da)
SI (2)	SI1946769T1 (da)
SK (1)	SK288007B6 (da)
UA (2)	UA85853C2 (da)
UY (1)	UY26801A1 (da)
WO (1)	WO2002000249A2 (da)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4540795B2 (ja) *	2000-03-10	2010-09-08	一般財団法人阪大微生物病研究会	生ワクチンの細胞性免疫活性を不活化ワクチンにも起こさせる方法、及びこれより得られる混合ワクチン
ATE534402T1 (de)	2000-06-29	2011-12-15	Smithkline Beecham Biolog	Multivalente impfstoffzusammensetzung
GB0108364D0 (en) *	2001-04-03	2001-05-23	Glaxosmithkline Biolog Sa	Vaccine composition
CA2435681C (en)	2001-01-23	2011-06-21	Aventis Pasteur	Multivalent meningococcal polysaccharide-protein conjugate vaccine
AU2007200116A1 (en) *	2001-04-03	2007-02-01	Glaxosmithkline Biologicals S.A.	Vaccine composition
WO2002099035A2 (en)	2001-05-31	2002-12-12	Chiron Corporation	Chimeric alphavirus replicon particles
GB0115176D0 (en)	2001-06-20	2001-08-15	Chiron Spa	Capular polysaccharide solubilisation and combination vaccines
MXPA04011249A (es)	2002-05-14	2005-06-06	Chiron Srl	Vacunas mucosales con adyuvante de quitosano y antigenos meningococicos.
CA2485999C (en) *	2002-05-14	2015-02-17	Chiron Srl	Mucosal combination vaccines for bacterial meningitis
GB0302218D0 (en)	2003-01-30	2003-03-05	Chiron Sri	Vaccine formulation & Mucosal delivery
SI2351579T1 (sl)	2002-10-11	2017-05-31	Glaxosmithkline Biologicals Sa	Polipeptidna cepiva za široko zaščito proti hipervirulentnim meningokoknim linijam
MY145693A (en) *	2002-11-01	2012-03-30	Glaxosmithkline Biolog Sa	A method of drying without freezing or bubbling
GB0227346D0 (en)	2002-11-22	2002-12-31	Chiron Spa	741
CA2514328C (en) *	2003-01-30	2020-01-14	Chiron Srl	Injectable vaccines against multiple meningococcal serogroups
JP2006516609A (ja) *	2003-01-30	2006-07-06	カイロンソチエタアレスポンサビリタリミタータ	粘膜髄膜炎菌性ワクチン
CN1819843A (zh)	2003-05-07	2006-08-16	安万特巴斯德公司	增强脑膜炎球菌疫苗接种免疫原性的方法
GB0313916D0 (en)	2003-06-16	2003-07-23	Glaxosmithkline Biolog Sa	Vaccine composition
WO2005000345A2 (en) *	2003-06-23	2005-01-06	Aventis Pasteur, Inc.	Immunization method against neisseria meningitidis serogroups a and c
GB0323103D0 (en)	2003-10-02	2003-11-05	Chiron Srl	De-acetylated saccharides
AU2004277758A1 (en) *	2003-10-02	2005-04-14	Novartis Vaccines And Diagnostics S.R.L.	Liquid vaccines for multiple meningococcal serogroups
CU23404A1 (es) *	2003-11-19	2009-08-04	Ct Ingenieria Genetica Biotech	Polisacáridos capsulares de neisseria meningitidis como inmunopotenciadores mucosales y formulaciones resultantes
GB0405787D0 (en) *	2004-03-15	2004-04-21	Chiron Srl	Low dose vaccines
GB0500787D0 (en)	2005-01-14	2005-02-23	Chiron Srl	Integration of meningococcal conjugate vaccination
GB0409745D0 (en)	2004-04-30	2004-06-09	Chiron Srl	Compositions including unconjugated carrier proteins
EP1740217B1 (en)	2004-04-30	2011-06-15	Novartis Vaccines and Diagnostics S.r.l.	Meningococcal conjugate vaccination
GB0502096D0 (en)	2005-02-01	2005-03-09	Chiron Srl	Purification of streptococcal capsular polysaccharide
GB0505518D0 (en) *	2005-03-17	2005-04-27	Chiron Srl	Combination vaccines with whole cell pertussis antigen
CN113198013B (zh)	2005-04-08	2024-02-20	惠氏有限责任公司	多价肺炎球菌多糖－蛋白质缀合物组合物
US20070184072A1 (en) *	2005-04-08	2007-08-09	Wyeth	Multivalent pneumococcal polysaccharide-protein conjugate composition
US7955605B2 (en)	2005-04-08	2011-06-07	Wyeth Llc	Multivalent pneumococcal polysaccharide-protein conjugate composition
US7709001B2 (en) *	2005-04-08	2010-05-04	Wyeth Llc	Multivalent pneumococcal polysaccharide-protein conjugate composition
CA2605179A1 (en)	2005-04-18	2006-10-26	Novartis Vaccines And Diagnostics, Inc.	Expressing hepatitis b virus surface antigen for vaccine preparation
SI1896063T1 (sl)	2005-06-27	2012-03-30	Glaxosmithkline Biolog Sa	Imunogeni sestavek
GB0513069D0 (en) *	2005-06-27	2005-08-03	Glaxosmithkline Biolog Sa	Immunogenic composition
CN1709505B (zh) *	2005-07-13	2010-06-16	北京绿竹生物制药有限公司	多价细菌荚膜多糖-蛋白质结合物联合疫苗
BRPI0615420A2 (pt)	2005-09-01	2011-05-17	Novartis Vaccines & Diagnostic	vacinação múltipla que inclui meningococo do sorogrupo c
JP2009511636A (ja)	2005-10-18	2009-03-19	ノバルティスヴァクシンズアンドダイアグノスティクス，インコーポレイテッド	アルファウイルスレプリコン粒子による粘膜免疫および全身免疫
GB0522765D0 (en)	2005-11-08	2005-12-14	Chiron Srl	Combination vaccine manufacture
GB0524066D0 (en)	2005-11-25	2006-01-04	Chiron Srl	741 ii
EA014107B1 (ru) *	2005-12-22	2010-10-29	Глаксосмитклайн Байолоджикалс С.А.	Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
GB0607088D0 (en) *	2006-04-07	2006-05-17	Glaxosmithkline Biolog Sa	Vaccine
EA200801368A1 (ru) *	2005-12-23	2008-12-30	Глаксосмитклайн Байолоджикалс С.А.	Конъюгатные вакцины
BRPI0707154B8 (pt) *	2006-01-17	2022-12-20	Forsgren Arne	composição de vacina
US20080026002A1 (en)	2006-03-22	2008-01-31	Lisa Danzig	Regimens for immunisation with meningococcal conjugates
TW200806315A (en) *	2006-04-26	2008-02-01	Wyeth Corp	Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
US8808707B1 (en)	2006-05-08	2014-08-19	Wyeth Llc	Pneumococcal dosing regimen
EP1872791A1 (en)	2006-06-30	2008-01-02	Institut Pasteur	Use of bacterial polysaccharides for biofilm inhibition
EP2066344B2 (en) *	2006-09-07	2016-06-29	GlaxoSmithKline Biologicals S.A.	Inactivated Poliovirus combination vaccine
EA201490303A1 (ru)	2007-05-02	2014-05-30	Глаксосмитклайн Байолоджикалс С.А.	Вакцина
RU2009149359A (ru)	2007-06-04	2011-07-20	Новартис АГ (CH)	Состав вакцин против менингита
PT2167121E (pt)	2007-06-26	2015-12-02	Glaxosmithkline Biolog Sa	Vacina compreendendo conjugados de polissacáridos capsulares de streptococcus pneumoniae
GB0818453D0 (en)	2008-10-08	2008-11-12	Novartis Ag	Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
MX2010012999A (es) *	2008-05-30	2012-03-07	U S A As Represented By The Secretary Of The Army On Behalf Of Walter Reed Army	Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso.
PE20100365A1 (es) *	2008-10-24	2010-05-21	Panacea Biotec Ltd	Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion
GB0822633D0 (en)	2008-12-11	2009-01-21	Novartis Ag	Formulation
GB0822634D0 (en)	2008-12-11	2009-01-21	Novartis Ag	Meningitis vaccines
TW201136603A (en) *	2010-02-09	2011-11-01	Merck Sharp & Amp Dohme Corp	15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
ES2764674T3 (es) *	2010-06-04	2020-06-04	Wyeth Llc	Formulaciones vacunales
MX344280B (es) *	2010-12-14	2016-12-09	Glaxosmithkline Biologicals Sa	Composicion antigenica de micobacteria.
EP3459562B1 (en)	2011-01-05	2024-03-20	Bharat Biotech International Limited	A combination heptavalent vaccine
GB201105981D0 (en)	2011-04-08	2011-05-18	Glaxosmithkline Biolog Sa	Novel process
EP2592137A1 (en)	2011-11-11	2013-05-15	Novartis AG	Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use
DE102011118371B4 (de)	2011-11-11	2014-02-13	Novartis Ag	Zur Impfung von Menschen geeignete Zusammensetzung, die ein Diphtherie-Toxoid umfasst, sowie Verfahren zu deren Herstellung
DE102011122891B4 (de)	2011-11-11	2014-12-24	Novartis Ag	Fermentationsmedium, das frei von tierischen Bestandteilen ist, zur Herstellung von Diphtherie-Toxoiden zur Verwendung bei der Impfung von Menschen
GB2495341B (en)	2011-11-11	2013-09-18	Novartis Ag	Fermentation methods and their products
SG11201404447WA (en) *	2012-01-30	2014-08-28	Serum Inst India Ltd	Immunogenic composition
US20150125486A1 (en) *	2012-03-08	2015-05-07	Novartis Ag	Adjuvanted formulations of pediatric antigens
JP2015525794A (ja)	2012-08-06	2015-09-07	グラクソスミスクラインバイオロジカルズソシエテアノニム	乳児においてｒｓｖ及び百日咳菌に対する免疫応答を惹起するための方法
US20140037680A1 (en)	2012-08-06	2014-02-06	Glaxosmithkline Biologicals, S.A.	Novel method
CA2886938A1 (en)	2012-10-12	2014-04-17	Glaxosmithkline Biologicals S.A.	Non-cross-linked acellular pertussis antigens for use in combination vaccines
ES2640320T3 (es) *	2012-10-17	2017-11-02	Glaxosmithkline Biologicals S.A.	Composición inmunogénica que comprende 1 o más conjugados de sacáridos capsulares de Streptococcus pneumoniae y un componente proteico que comprende proteína E y/o PilA de Haemophilus influenzae
KR20140075201A (ko) *	2012-12-11	2014-06-19	에스케이케미칼주식회사	다가 폐렴구균 다당류-단백질 접합체 조성물
EA030749B1 (ru)	2013-03-08	2018-09-28	Янссен Вэксинс Энд Превеншн Б.В.	Бесклеточная противококлюшная вакцина
SG11201600042YA (en) *	2013-07-07	2016-02-26	Max Planck Ges Zur Förderung Der Wissenschaften E V	Synthetic vaccines against streptococcus pneumoniae type 1
BR112016002354A2 (pt)	2013-08-05	2017-09-12	Glaxosmithkline Biologicals Sa	composição imunogênica, métodos para proteger um bebê contra infecção ou doença e para evocar uma resposta imune, regime de vacinação, e, kit
US11160855B2 (en)	2014-01-21	2021-11-02	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
US9107906B1 (en)	2014-10-28	2015-08-18	Adma Biologics, Inc.	Compositions and methods for the treatment of immunodeficiency
RU2626532C2 (ru) *	2015-01-16	2017-07-28	Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации	Комбинированная вакцина для профилактики коклюша, дифтерии, столбняка, гепатита в и инфекции, вызываемой haemophilus influenzae тип в
CN107249626A (zh) *	2015-02-19	2017-10-13	辉瑞大药厂	脑膜炎奈瑟球菌组合物及其方法
SG11201900789VA (en)	2016-08-05	2019-02-27	Sanofi Pasteur Inc	Multivalent pneumococcal polysaccharide-protein conjugate composition
EP3493837B1 (en)	2016-08-05	2022-08-31	Sanofi Pasteur, Inc.	Multivalent pneumococcal polysaccharide-protein conjugate composition
AU2017321863B2 (en)	2016-09-02	2024-07-11	Sanofi Pasteur, Inc.	Neisseria meningitidis vaccine
US10259865B2 (en)	2017-03-15	2019-04-16	Adma Biologics, Inc.	Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
MX2020005779A (es)	2017-12-06	2020-10-28	Merck Sharp & Dohme	Composiciones que comprenden conjugados de polisacarido de streptococcus pneumoniae con proteina y metodos de uso de estos.
WO2019152925A1 (en)	2018-02-05	2019-08-08	Sanofi Pasteur Inc.	Multivalent pneumococcal polysaccharide-protein conjugate composition
US11147864B2 (en)	2018-02-05	2021-10-19	Sanofi Pasteur Inc.	Multivalent pneumococcal polysaccharide-protein conjugate composition
EP3782642A4 (en)	2018-04-18	2022-04-13	SK Bioscience Co., Ltd.	Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof
WO2019212844A1 (en) *	2018-04-30	2019-11-07	Merck Sharp & Dohme Corp.	Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide
KR20200005458A (ko)	2018-07-06	2020-01-15	주식회사 유바이오로직스	다가 폐렴구균 다당체-단백질 접합체를 포함하는 면역원성 조성물, 및 이를 포함하는 약학 조성물
KR20210092224A (ko) *	2018-11-10	2021-07-23	브하라트 바이오테크 인터내셔날 리미티드	다가 당접합체 면역원성 조성물
KR20240169145A (ko)	2018-12-19	2024-12-02	머크 샤프 앤드 돔 엘엘씨	스트렙토코쿠스 뉴모니아에 폴리사카라이드-단백질 접합체를 포함하는 조성물 및 그의 사용 방법
SG11202112887TA (en)	2019-05-20	2021-12-30	Soligenix Inc	Compositions and methods of manufacturing trivalent filovirus vaccines
CN111821432B (zh) *	2020-08-05	2022-10-18	北京智飞绿竹生物制药有限公司	一种多价肺炎球菌结合疫苗

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4057685A (en) *	1972-02-02	1977-11-08	Abbott Laboratories	Chemically modified endotoxin immunizing agent
US4235877A (en) *	1979-06-27	1980-11-25	Merck & Co., Inc.	Liposome particle containing viral or bacterial antigenic subunit
DE3071552D1 (en) *	1979-09-21	1986-05-22	Hitachi Ltd	Semiconductor switch
US4372945A (en)	1979-11-13	1983-02-08	Likhite Vilas V	Antigen compounds
IL61904A (en)	1981-01-13	1985-07-31	Yeda Res & Dev	Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
US4673574A (en) *	1981-08-31	1987-06-16	Anderson Porter W	Immunogenic conjugates
US4459286A (en) *	1983-01-31	1984-07-10	Merck & Co., Inc.	Coupled H. influenzae type B vaccine
JPS6061288A (ja) *	1983-09-13	1985-04-09	Fuji Photo Film Co Ltd	感熱記録材料
US4808700A (en) *	1984-07-09	1989-02-28	Praxis Biologics, Inc.	Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
US4709017A (en)	1985-06-07	1987-11-24	President And Fellows Of Harvard College	Modified toxic vaccines
GB8516442D0 (en)	1985-06-28	1985-07-31	Wellcome Found	Cloned antigen
GB8727489D0 (en)	1987-11-24	1987-12-23	Connaught Lab	Detoxification of pertussis toxin
GB8914122D0 (en)	1989-06-20	1989-08-09	Wellcome Found	Polypeptide expression
SE466259B (sv)	1990-05-31	1992-01-20	Arne Forsgren	Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
CA2059692C (en) *	1991-01-28	2004-11-16	Peter J. Kniskern	Pneumoccoccal polysaccharide conjugate vaccine
CA2135052A1 (en)	1992-05-06	1993-11-11	R. John Collier	Diphtheria toxin receptor-binding region
DK0835663T3 (da)	1992-05-23	2010-02-01	Glaxosmithkline Biolog Sa	Kombinerede vacciner omfattende Hepatitis B overfladeantigen og andre antigener
PT652758E (pt)	1992-06-18	2000-04-28	Harvard College	Vacinas de toxina da difteria
DK0761231T3 (da)	1992-06-25	2000-05-08	Smithkline Beecham Biolog	Vaccinepræparat indeholdende adjuvanser
DE69323264T4 (de) *	1992-10-27	1999-10-14	American Cyanamid Co.	Pädiatrische Kombinationsvakzine mit verbesserter Immunogenizität jeder Vakzine komponente
US5849301A (en) *	1993-09-22	1998-12-15	Henry M. Jackson Foundation For The Advancement Of Military Medicine	Producing immunogenic constructs using soluable carbohydrates activated via organic cyanylating reagents
CA2171942C (en)	1993-09-22	2010-12-14	Andrew Lees	Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
GB9326253D0 (en)	1993-12-23	1994-02-23	Smithkline Beecham Biolog	Vaccines
US5869058A (en) *	1994-05-25	1999-02-09	Yeda Research And Development Co. Ltd.	Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
US5917017A (en)	1994-06-08	1999-06-29	President And Fellows Of Harvard College	Diphtheria toxin vaccines bearing a mutated R domain
US6455673B1 (en) *	1994-06-08	2002-09-24	President And Fellows Of Harvard College	Multi-mutant diphtheria toxin vaccines
WO1996002555A1 (en)	1994-07-15	1996-02-01	The University Of Iowa Research Foundation	Immunomodulatory oligonucleotides
GB9422096D0 (en) *	1994-11-02	1994-12-21	Biocine Spa	Combined meningitis vaccine
UA56132C2 (uk)	1995-04-25	2003-05-15	Смітклайн Бічем Байолоджікалс С.А.	Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
NZ312132A (en) *	1995-06-23	1999-04-29	Smithkline Beecham Biolog	A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
US5997881A (en)	1995-11-22	1999-12-07	University Of Maryland, Baltimore	Method of making non-pyrogenic lipopolysaccharide or A
WO1998033923A1 (en)	1997-01-30	1998-08-06	Imperial College Of Science, Technology & Medicine	MUTANT msbB or htrB GENES
WO1999013906A1 (en) *	1997-09-15	1999-03-25	Pasteur Merieux Msd	Multivalent vaccines
US5965714A (en) *	1997-10-02	1999-10-12	Connaught Laboratories, Inc.	Method for the covalent attachment of polysaccharides to protein molecules
US7018637B2 (en)	1998-02-23	2006-03-28	Aventis Pasteur, Inc	Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
GB9806456D0 (en) *	1998-03-25	1998-05-27	Smithkline Beecham Biolog	Vaccine composition
US6146902A (en) *	1998-12-29	2000-11-14	Aventis Pasteur, Inc.	Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
GB9925559D0 (en)	1999-10-28	1999-12-29	Smithkline Beecham Biolog	Novel method
FR2806304B1 (fr) *	2000-03-17	2002-05-10	Aventis Pasteur	Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie
GB0108364D0 (en) *	2001-04-03	2001-05-23	Glaxosmithkline Biolog Sa	Vaccine composition
ATE534402T1 (de)	2000-06-29	2011-12-15	Smithkline Beecham Biolog	Multivalente impfstoffzusammensetzung
AU2003257003A1 (en) *	2002-07-30	2004-02-16	Baxter Healthcare S.A.	Chimeric multivalent polysaccharide conjugate vaccines
GB0405787D0 (en) *	2004-03-15	2004-04-21	Chiron Srl	Low dose vaccines
GB0500787D0 (en) *	2005-01-14	2005-02-23	Chiron Srl	Integration of meningococcal conjugate vaccination
GB0428394D0 (en) *	2004-12-24	2005-02-02	Chiron Srl	Saccharide conjugate vaccines
GB0502095D0 (en) *	2005-02-01	2005-03-09	Chiron Srl	Conjugation of streptococcal capsular saccharides
SI1896063T1 (sl) *	2005-06-27	2012-03-30	Glaxosmithkline Biolog Sa	Imunogeni sestavek
GB0607088D0 (en) *	2006-04-07	2006-05-17	Glaxosmithkline Biolog Sa	Vaccine
EA014107B1 (ru) *	2005-12-22	2010-10-29	Глаксосмитклайн Байолоджикалс С.А.	Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
EA200801368A1 (ru) *	2005-12-23	2008-12-30	Глаксосмитклайн Байолоджикалс С.А.	Конъюгатные вакцины
GB0700136D0 (en) *	2007-01-04	2007-02-14	Glaxosmithkline Biolog Sa	Process for manufacturing vaccines
GB0700135D0 (en) *	2007-01-04	2007-02-14	Glaxosmithkline Biolog Sa	Vaccine
US8885224B2 (en) *	2007-03-14	2014-11-11	Konica Minolta Business Technologies, Inc.	Information embedding method, its program and information embedding device
EA201490303A1 (ru) *	2007-05-02	2014-05-30	Глаксосмитклайн Байолоджикалс С.А.	Вакцина
RU2009149359A (ru) *	2007-06-04	2011-07-20	Новартис АГ (CH)	Состав вакцин против менингита
PT2167121E (pt) *	2007-06-26	2015-12-02	Glaxosmithkline Biolog Sa	Vacina compreendendo conjugados de polissacáridos capsulares de streptococcus pneumoniae

2001
- 2001-06-27 AT AT01960390T patent/ATE534402T1/de active
- 2001-06-27 OA OA1200200395A patent/OA12302A/en unknown
- 2001-06-27 KR KR1020087013186A patent/KR100898845B1/ko active IP Right Grant
- 2001-06-27 DK DK07116669.8T patent/DK1946769T3/da active
- 2001-06-27 WO PCT/EP2001/007288 patent/WO2002000249A2/en active IP Right Grant
- 2001-06-27 EA EA200501070A patent/EA011480B1/ru not_active IP Right Cessation
- 2001-06-27 BR BR122012003821A patent/BR122012003821B8/pt not_active IP Right Cessation
- 2001-06-27 KR KR1020027017928A patent/KR100837917B1/ko active IP Right Grant
- 2001-06-27 UY UY26801A patent/UY26801A1/es not_active IP Right Cessation
- 2001-06-27 SI SI200131012T patent/SI1946769T1/sl unknown
- 2001-06-27 SK SK1843-2002A patent/SK288007B6/sk not_active IP Right Cessation
- 2001-06-27 AU AU2001281895A patent/AU2001281895C1/en active Active
- 2001-06-27 IL IL15350601A patent/IL153506A0/xx unknown
- 2001-06-27 UA UAA200604994A patent/UA85853C2/uk unknown
- 2001-06-27 CN CN018146198A patent/CN1449293B/zh not_active Expired - Lifetime
- 2001-06-27 HU HU1000593A patent/HU227893B1/hu unknown
- 2001-06-27 NZ NZ523319A patent/NZ523319A/en not_active IP Right Cessation
- 2001-06-27 BR BRPI0112057A patent/BRPI0112057B8/pt not_active IP Right Cessation
- 2001-06-27 SI SI200131007T patent/SI1296715T2/sl unknown
- 2001-06-27 EA EA200201240A patent/EA006313B1/ru not_active IP Right Cessation
- 2001-06-27 AP APAP/P/2002/002700A patent/AP1695A/en active
- 2001-06-27 PT PT07116669T patent/PT1946769E/pt unknown
- 2001-06-27 MY MYPI20013027 patent/MY133981A/en unknown
- 2001-06-27 EP EP10178451A patent/EP2277541A1/en not_active Withdrawn
- 2001-06-27 EP EP10178449A patent/EP2279748A1/en not_active Withdrawn
- 2001-06-27 ES ES07116669T patent/ES2385100T3/es not_active Expired - Lifetime
- 2001-06-27 CZ CZ20024224A patent/CZ20024224A3/cs not_active IP Right Cessation
- 2001-06-27 CA CA2783274A patent/CA2783274C/en not_active Expired - Lifetime
- 2001-06-27 KR KR1020077019832A patent/KR20070091698A/ko not_active Application Discontinuation
- 2001-06-27 US US10/312,090 patent/US20030180316A1/en not_active Abandoned
- 2001-06-27 AU AU8189501A patent/AU8189501A/xx active Pending
- 2001-06-27 PT PT01960390T patent/PT1296715E/pt unknown
- 2001-06-27 HU HU1000594A patent/HU227613B1/hu unknown
- 2001-06-27 UA UA20021210397A patent/UA76952C2/uk unknown
- 2001-06-27 CN CN200910174266.7A patent/CN101708333B/zh not_active Expired - Lifetime
- 2001-06-27 DK DK01960390.1T patent/DK1296715T4/da active
- 2001-06-27 EP EP01960390.1A patent/EP1296715B2/en not_active Expired - Lifetime
- 2001-06-27 PL PL393584A patent/PL393584A1/pl unknown
- 2001-06-27 ES ES01960390.1T patent/ES2375704T5/es not_active Expired - Lifetime
- 2001-06-27 CA CA2412497A patent/CA2412497C/en not_active Expired - Lifetime
- 2001-06-27 JP JP2002505030A patent/JP4870895B2/ja not_active Expired - Lifetime
- 2001-06-27 DZ DZ013399A patent/DZ3399A1/xx active
- 2001-06-27 EG EG20010701A patent/EG24742A/xx active
- 2001-06-27 PL PL360265A patent/PL210015B1/pl unknown
- 2001-06-27 MX MXPA03000198A patent/MXPA03000198A/es active IP Right Grant
- 2001-06-27 EP EP07116669A patent/EP1946769B1/en not_active Expired - Lifetime
- 2001-06-27 PE PE2001000629A patent/PE20020126A1/es not_active Application Discontinuation
- 2001-06-27 HU HU0301413A patent/HU228384B1/hu unknown
2002
- 2002-12-17 IL IL153506A patent/IL153506A/en active IP Right Grant
- 2002-12-20 NO NO20026175A patent/NO332495B1/no not_active IP Right Cessation
- 2002-12-26 MA MA26980A patent/MA25824A1/fr unknown
- 2002-12-28 BG BG107422A patent/BG66238B1/bg active Active
2003
- 2003-08-27 HK HK03106153.7A patent/HK1055244A1/xx not_active IP Right Cessation
2009
- 2009-11-06 BG BG10110518A patent/BG66249B1/bg active Active
2010
- 2010-03-15 JP JP2010057779A patent/JP5346308B2/ja not_active Expired - Lifetime
2012
- 2012-01-30 CY CY20121100103T patent/CY1112280T1/el unknown
- 2012-04-04 US US13/439,829 patent/US9233151B2/en not_active Expired - Fee Related
- 2012-06-15 CY CY20121100549T patent/CY1112915T1/el unknown

Also Published As

Publication number	Publication date
BRPI0112057B8 (pt)	2021-05-25
EA006313B1 (ru)	2005-10-27
JP2004501873A (ja)	2004-01-22
EP1946769B1 (en)	2012-05-30
EP2279748A1 (en)	2011-02-02
KR100837917B1 (ko)	2008-06-13
NO332495B1 (no)	2012-10-01
SI1296715T2 (sl)	2016-03-31
HU228384B1 (en)	2013-03-28
US20120207780A1 (en)	2012-08-16
KR100898845B1 (ko)	2009-05-21
SK288007B6 (sk)	2012-10-02
HU227893B1 (en)	2012-05-29
IL153506A (en)	2009-06-15
EP1946769A2 (en)	2008-07-23
WO2002000249A2 (en)	2002-01-03
AP1695A (en)	2006-12-17
NO20026175D0 (no)	2002-12-20
EP2277541A1 (en)	2011-01-26
AU2001281895C1 (en)	2005-10-27
OA12302A (en)	2003-10-24
PL393584A1 (pl)	2011-05-23
AP2002002700A0 (en)	2002-12-31
MXPA03000198A (es)	2004-09-13
EA011480B1 (ru)	2009-04-28
BG66249B1 (en)	2012-09-28
CY1112915T1 (el)	2016-04-13
HU1000594D0 (en)	2010-12-28
EG24742A (en)	2010-07-14
CA2412497A1 (en)	2002-01-03
US9233151B2 (en)	2016-01-12
KR20030024714A (ko)	2003-03-26
DK1296715T4 (da)	2016-03-07
CN1449293A (zh)	2003-10-15
HU227613B1 (en)	2011-09-28
UA76952C2 (uk)	2006-10-16
EP1296715B1 (en)	2011-11-23
PL360265A1 (en)	2004-09-06
UY26801A1 (es)	2002-01-31
ATE534402T1 (de)	2011-12-15
MA25824A1 (fr)	2003-07-01
HU1000593D0 (en)	2010-12-28
NO20026175L (no)	2003-02-26
CA2783274A1 (en)	2002-01-03
WO2002000249A3 (en)	2002-06-13
CN1449293B (zh)	2012-08-22
PL210015B1 (pl)	2011-11-30
UA85853C2 (uk)	2009-03-10
PT1946769E (pt)	2012-06-27
ES2385100T3 (es)	2012-07-18
SI1296715T1 (sl)	2012-03-30
HUP0301413A1 (hu)	2003-08-28
JP5346308B2 (ja)	2013-11-20
KR20080052700A (ko)	2008-06-11
CY1112280T1 (el)	2015-12-09
PT1296715E (pt)	2012-01-19
MY133981A (en)	2007-11-30
SI1946769T1 (sl)	2012-07-31
IL153506A0 (en)	2003-07-06
AU2001281895B2 (en)	2005-04-28
BG66238B1 (bg)	2012-08-31
KR20070091698A (ko)	2007-09-11
HUP0301413A3 (en)	2010-01-28
CA2783274C (en)	2018-08-07
JP2010163453A (ja)	2010-07-29
BR122012003821B1 (pt)	2020-09-01
CA2412497C (en)	2012-10-02
EA200501070A1 (ru)	2006-02-24
EP1296715B2 (en)	2015-12-23
CZ20024224A3 (cs)	2003-05-14
BR0112057A (pt)	2003-06-17
BG110518A (bg)	2010-04-30
CN101708333B (zh)	2014-03-26
EA200201240A1 (ru)	2003-06-26
ES2375704T5 (es)	2016-03-03
BR122012003821B8 (pt)	2021-05-25
EP1296715A2 (en)	2003-04-02
EP1946769A3 (en)	2008-07-30
NZ523319A (en)	2006-01-27
DK1946769T3 (da)	2012-07-16
BRPI0112057B1 (pt)	2016-10-04
JP4870895B2 (ja)	2012-02-08
ES2375704T3 (es)	2012-03-05
BG107422A (bg)	2003-09-30
CN101708333A (zh)	2010-05-19
SK18432002A3 (sk)	2003-08-05
AU8189501A (en)	2002-01-08
US20030180316A1 (en)	2003-09-25
HK1055244A1 (en)	2004-01-02
PE20020126A1 (es)	2002-04-27
DZ3399A1 (fr)	2002-01-03

Publication	Publication Date	Title
DK1296715T3 (da)	2012-02-13	Multivalent vaccinesammensætning
DK1946772T3 (da)	2012-07-16	Multivalent vaccinesammensætning
NO20031483L (no)	2003-05-28	Vaksine
NO20024172D0 (no)	2002-09-02	Vaksine
PL363005A1 (pl)	2004-11-15	Szczepionki
ATE490327T1 (de)	2010-12-15	Impfstoffzusammensetzung
DE60027029D1 (de)	2006-05-18	Kombinierte impfstoffzusammensetzungen
NO20031705D0 (no)	2003-04-11	Vaksiner
NO20014325D0 (no)	2001-09-05	Vaksine
FR14C0016I2 (fr)	2015-07-24	Vacccin west nile
IS2932B (is)	2015-12-15	Fúlvestrant samsetning
DK1265633T3 (da)	2013-01-07	Vaccineadjuvans
DE60002650D1 (de)	2003-06-18	Öladjuvierter Impfstoff
NO20020763D0 (no)	2002-02-15	Vaksine
DK1267899T3 (da)	2005-12-12	ssa-inaktiverede salmonellavacciner
NO20033882D0 (no)	2003-09-02	Vaksine
DE60116858D1 (de)	2006-04-13	Zusammensetzung
IDP000026013A (id)	2001-08-23	Komposisi biolakto-aktif